| 19327170 | CDK4 IVS4-nt40 AA genotype and obesity-associated tumors/cancer in Italians - a case-control study. | J Exp Clin Cancer Res | 2009 Mar 28 | Meenakshisundaram R | doi: 10.1186/1756-9966-28-42. |
| 29935356 | Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4. | Gene | 2018 Oct 30 | Qin Y | doi: 10.1016/j.gene.2018.06.062 |
| 24289491 | MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. | Pigment Cell Melanoma Res | 2014 Mar | Georgantas RW 3rd | doi: 10.1111/pcmr.12200 |
| 21325289 | Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. | Clin Cancer Res | 2011 Apr 1 | Yu J | doi: 10.1158/1078-0432.CCR-10-1551 |
| 24771220 | Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma. | Tumour Biol | 2014 Jul | Chen TJ | doi: 10.1007/s13277-014-1884-2 |
| 24751144 | Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma. | BMC Cancer | 2014 Apr 21 | Liu Z | doi: 10.1186/1471-2407-14-274. |
| 18413728 | Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. | Cancer Res | 2008 Apr 15 | Molenaar JJ | doi: 10.1158/0008-5472.CAN-07-5032. |
| 24496383 | Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery. | Mol Ther | 2014 May | Mao CQ | doi: 10.1038/mt.2014.18 |
| 25002028 | CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors. | Cancer Cell | 2014 Jul 14 | Vora SR | doi: 10.1016/j.ccr.2014.05.020 |
| 26336885 | Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas. | Mod Pathol | 2015 Nov | Saada-Bouzid E | doi: 10.1038/modpathol.2015.96 |
| 14647432 | Enhanced malignant tumorigenesis in Cdk4 transgenic mice. | Oncogene | 2004 Mar 11 | Miliani de Marval PL | - |
| 17139501 | Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. | Virchows Arch | 2007 Feb | Nadal A | - |
| 24614102 | CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. | J Clin Invest | 2014 Apr | Lu Y | doi: 10.1172/JCI63139 |
| 27508976 | MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective. | Am J Surg Pathol | 2016 Dec | Clay MR | - |
| 27597521 | Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. | Hum Pathol | 2017 Jan | Kammerer-Jacquet SF | doi: 10.1016/j.humpath.2016.08.009 |
| 26923330 | Targeting the RB-E2F pathway in breast cancer. | Oncogene | 2016 Sep 15 | Johnson J | doi: 10.1038/onc.2016.32 |
| 27542767 | A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas. | Clin Cancer Res | 2016 Dec 1 | Infante JR | - |
| 28039467 | Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. | Oncotarget | 2017 Feb 7 | Bonuccelli G | doi: 10.18632/oncotarget.14196. |
| 28351928 | Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors. | Clin Cancer Res | 2017 Jul 1 | Tripathy D | doi: 10.1158/1078-0432.CCR-16-3157 |
| 29562955 | MicroRNA-338-3p Inhibits Proliferation and Promotes Apoptosis of Multiple Myeloma Cells Through Targeting Cyclin-Dependent Kinase 4. | Oncol Res | 2018 Dec 27 | Cao Y | doi: 10.3727/096504018X15213031799835 |
| 25348738 | MiR-124 retards bladder cancer growth by directly targeting CDK4. | Acta Biochim Biophys Sin (Shanghai) | 2014 Dec | Zhang T | doi: 10.1093/abbs/gmu105 |
| 24982332 | Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors. | Anticancer Res | 2014 Jul | Poi MJ | - |
| 15208653 | Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc. | Oncogene | 2004 Aug 12 | Pawar SA | - |
| 23839043 | Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. | Cell Cycle | 2013 Aug 1 | Lamb R | doi: 10.4161/cc.25403 |
| 23336272 | The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. | Breast Cancer Res | 2013 Jan 21 | Peurala E | doi: 10.1186/bcr3376. |
| 27323123 | miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4. | Genet Mol Res | 2016 Jun 3 | Zhang YH | doi: 10.4238/gmr.15027893. |
| 16413469 | Requirement for CDK4 kinase function in breast cancer. | Cancer Cell | 2006 Jan | Yu Q | - |
| 14672406 | Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development. | Mol Biol Rep | 2003 Dec | Mishra R | - |
| 26416047 | Genetic polymorphisms in cell cycle regulatory genes CCND1 and CDK4 are associated with susceptibility to breast cancer. | J BUON | 2015 Jul-Aug | Ullah Shah A | - |
| 20179208 | Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. | Cancer Res | 2010 Mar 1 | Zhong Z | doi: 10.1158/0008-5472.CAN-08-1108 |
| 18202766 | Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells. | Int J Oncol | 2008 Feb | Shin JS | - |
| 24444383 | Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells. | BMC Cancer | 2014 Jan 20 | Kang J | doi: 10.1186/1471-2407-14-32. |
| 23776583 | Cdk4 and nek2 signal binucleation and centrosome amplification in a her2+ breast cancer model. | PLoS One | 2013 Jun 11 | Harrison Pitner MK | doi: 10.1371/journal.pone.0065971 |
| 23684928 | Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells. | Cancer Lett | 2013 Sep 1 | Gulappa T | doi: 10.1016/j.canlet.2013.05.014 |
| 21278246 | Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer. | Clin Cancer Res | 2011 Mar 15 | Konecny GE | doi: 10.1158/1078-0432.CCR-10-2307 |
| 26735582 | RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression. | Oncotarget | 2016 Feb 2 | Liao A | doi: 10.18632/oncotarget.6813. |
| 23174577 | [Cytoplasmic expression of CDK4 protein and its correlation with the clinicopathologic features and prognosis of lung cancer]. | Nan Fang Yi Ke Da Xue Xue Bao | 2012 Nov | Zhang Y | - |
| 24848372 | Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. | PLoS One | 2014 May 21 | Jia Y | doi: 10.1371/journal.pone.0097448 |
| 22289176 | Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. | FEBS Lett | 2012 Feb 17 | Lin Y | doi: 10.1016/j.febslet.2012.01.027 |
| 21477379 | Elevated expression of CDK4 in lung cancer. | J Transl Med | 2011 Apr 11 | Wu A | doi: 10.1186/1479-5876-9-38. |
| 21777578 | The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. | Exp Mol Pathol | 2011 Oct | Feng Z | doi: 10.1016/j.yexmp.2011.06.004 |
| 26744345 | MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer. | Cell Oncol (Dordr) | 2016 Apr | Li D | doi: 10.1007/s13402-015-0262-4 |
| 25486477 | The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis. | Cell Cycle | 2014 | Jirawatnotai S | doi: 10.4161/15384101.2014.946850. |
| 25876993 | The Role of CDK4/6 Inhibition in Breast Cancer. | Oncologist | 2015 May | Murphy CG | doi: 10.1634/theoncologist.2014-0443 |
| 19917880 | Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. | Mol Pharmacol | 2010 Feb | Barhoover MA | doi: 10.1124/mol.109.059675 |
| 27815686 | CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker. | Clin Transl Oncol | 2017 May | Banerjee J | doi: 10.1007/s12094-016-1565-2 |
| 27206849 | A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence. | Cancer Res | 2016 Jun 1 | Acevedo M | doi: 10.1158/0008-5472.CAN-15-2347 |
| 28364361 | A novel method to generate single-cell-derived cancer-associated fibroblast clones. | J Cancer Res Clin Oncol | 2017 Aug | Hashimoto H | doi: 10.1007/s00432-017-2409-3 |
| 28888575 | Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4. | Gene | 2017 Nov 30 | Chen S | doi: 10.1016/j.gene.2017.09.009 |
| 27049724 | Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer. | Oncotarget | 2016 Jun 7 | Shao Y | doi: 10.18632/oncotarget.8514. |
| 28508842 | A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines. | J Cancer Res Ther | 2017 Jan-Mar | Joshaghani HR | doi: 10.4103/0973-1482.199381. |
| 27564114 | Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2- breast cancer. | Oncotarget | 2016 Oct 25 | Knudsen ES | doi: 10.18632/oncotarget.11588. |
| 27759034 | CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer. | Sci Rep | 2016 Oct 19 | Dai M | doi: 10.1038/srep35383. |
| 29115564 | miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2. | Oncol Rep | 2018 Jan | Lang B | doi: 10.3892/or.2017.6064 |
| 29335521 | Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4. | Oncogene | 2018 Mar | Jia W | doi: 10.1038/s41388-017-0072-4 |
